Preveon
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Long-term management of HIV shows that combination therapy can achieve viral loads of under 50 copies, sustainable for 3 years…
Updates are provided for new anti-HIV drugs currently in development. ABT-378, Tipranavir, and DMP-450 are among the new…
The FDA's Antiviral Drugs Advisory Committee voted against approval of adefovir dipivoxil (Preveon) for treating HIV. Although…
More antiretroviral drugs are becoming available, increasing potential treatment regimens but also increasing the complexity of…
A Food and Drug Administration (FDA) advisory panel recommended against accelerated approval for adefovir dipivoxil (Preveon…
The trial program for adefovir dipivoxil (preveon), an anti-HIV drug, has been expanded to include individuals whose current…
Gilead Sciences, makers of adefovir dipivoxil (preveon), has observed varying levels of kidney-related abnormalities in…
Gilead Sciences has modified its expanded access program for its experimental antiviral adefovir dipivoxil (Preveon). Entry…
Gilead Sciences is removing the CD-4 and viral load requirements for people to enter its expanded access program for adefovir…